rs3791782

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_005259.3(MSTN):​c.*1332A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0241 in 152,600 control chromosomes in the GnomAD database, including 155 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.024 ( 155 hom., cov: 32)
Exomes 𝑓: 0.0028 ( 0 hom. )

Consequence

MSTN
NM_005259.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.637

Publications

2 publications found
Variant links:
Genes affected
MSTN (HGNC:4223): (myostatin) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer. This protein negatively regulates skeletal muscle cell proliferation and differentiation. Mutations in this gene are associated with increased skeletal muscle mass in humans and other mammals. [provided by RefSeq, Jul 2016]
C2orf88 (HGNC:28191): (chromosome 2 open reading frame 88) Predicted to enable protein kinase A regulatory subunit binding activity. Predicted to be located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 2-190055926-T-C is Benign according to our data. Variant chr2-190055926-T-C is described in ClinVar as Benign. ClinVar VariationId is 333218.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.164 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005259.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSTN
NM_005259.3
MANE Select
c.*1332A>G
3_prime_UTR
Exon 3 of 3NP_005250.1O14793

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSTN
ENST00000260950.5
TSL:1 MANE Select
c.*1332A>G
3_prime_UTR
Exon 3 of 3ENSP00000260950.3O14793
C2orf88
ENST00000917871.1
c.-234-24028T>C
intron
N/AENSP00000587930.1
C2orf88
ENST00000478197.1
TSL:4
n.220-23297T>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0241
AC:
3670
AN:
152130
Hom.:
154
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0429
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0467
Gnomad ASJ
AF:
0.00836
Gnomad EAS
AF:
0.173
Gnomad SAS
AF:
0.00806
Gnomad FIN
AF:
0.00141
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.00203
Gnomad OTH
AF:
0.0249
GnomAD4 exome
AF:
0.00282
AC:
1
AN:
354
Hom.:
0
Cov.:
0
AF XY:
0.00463
AC XY:
1
AN XY:
216
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.00286
AC:
1
AN:
350
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AF:
0.00
AC:
0
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.0242
AC:
3680
AN:
152246
Hom.:
155
Cov.:
32
AF XY:
0.0241
AC XY:
1795
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.0428
AC:
1779
AN:
41554
American (AMR)
AF:
0.0473
AC:
722
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.00836
AC:
29
AN:
3468
East Asian (EAS)
AF:
0.174
AC:
901
AN:
5190
South Asian (SAS)
AF:
0.00766
AC:
37
AN:
4832
European-Finnish (FIN)
AF:
0.00141
AC:
15
AN:
10616
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.00204
AC:
139
AN:
67998
Other (OTH)
AF:
0.0242
AC:
51
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
174
348
523
697
871
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0128
Hom.:
24
Bravo
AF:
0.0331
Asia WGS
AF:
0.0580
AC:
200
AN:
3446

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Myostatin-related muscle hypertrophy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
3.4
DANN
Benign
0.72
PhyloP100
0.64
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3791782; hg19: chr2-190920652; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.